Timothy Tombe, a Director, acquired 500,000 Common Shares on an indirect ownership basis for registered holder 0768390 BC Ltd. at a price of $1.000 through a prospectus or prospectus exempt offering on August 14th, 2017. The insider also acquired 250,000 Warrants with an exercise price of $1.500 for one year. This represents a $500,000 investment into the company's shares and an account share holdings change of greater than 100%.
In addition, David Gervais, a Director, acquired 340,000 Common Shares and 170,000 Warrants on a direct ownership basis. This represents a $340,000 investment into the company's shares and an account share holdings change of 6.4%.
Valens Groworks is in the Biotechnology & Medical Research Sub Industry Group under the Healthcare Sector.
Valens Groworks Corp, formerly Genovation Capital Corp., is a Canada-based company, which operates as a biotechnology company in the Okanagan Valley of British Columbia. The Company is focused on the cannabis cultivation and research business. The Company's research and development facility is located in Kelowna, British Columbia. The Company provides activities of cultivation, production (extraction), packaging, possession, sale, transportation, delivery and research of medical cannabis.
No Comments